<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03660462</url>
  </required_header>
  <id_info>
    <org_study_id>HiFe</org_study_id>
    <nct_id>NCT03660462</nct_id>
  </id_info>
  <brief_title>Iron Bioavailability of High Surface Area Ferric Phosphate</brief_title>
  <acronym>HiFe</acronym>
  <official_title>Iron Bioavailability of High Surface Area Ferric Phosphate in Thai Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swiss Federal Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Swiss Federal Institute of Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to compare iron absorption of high surface area ferric&#xD;
      phosphate with that of ferrous sulfate and bulk ferric phosphate in a rice-based meal in&#xD;
      non-pregnant women.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 21, 2018</start_date>
  <completion_date type="Actual">July 19, 2019</completion_date>
  <primary_completion_date type="Actual">June 19, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fractional iron absorption</measure>
    <time_frame>Measured 14 days after consumption of the 4 different types of iron vehicles (Days 16 and 31)</time_frame>
    <description>Iron absorption will be determined by measurement of the isotopic ratio change from the 4 different types of iron vehicles (FeSO4 fortified rice test meal, FePO4 fortified rice test meal, HiFePO4 1 fortified rice test meal, HiFePO4 2 fortified rice test meal).</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Iron-deficiency</condition>
  <arm_group>
    <arm_group_label>FeSO4 fortified rice test meal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>FePO4 fortified rice test meal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HiFePO4 1 fortified rice test meal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HiFePO4 2 fortified rice test meal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>FeSO4 fortified rice test meal</intervention_name>
    <description>Rice test meal extrinsically labeled with 2 mg ferrous sulfate (58FeSO4)</description>
    <arm_group_label>FeSO4 fortified rice test meal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>FePO4 fortified rice test meal</intervention_name>
    <description>Rice test meal extrinsically labeled with 2 mg ferric phosphate (58FePO4)</description>
    <arm_group_label>FePO4 fortified rice test meal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HiFePO4 1 fortified rice test meal</intervention_name>
    <description>Rice test meal extrinsically labeled with 2 mg high surface ferric phosphate 1 (57FePO4)</description>
    <arm_group_label>HiFePO4 1 fortified rice test meal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HiFePO4 2 fortified rice test meal</intervention_name>
    <description>Rice test meal extrinsically labeled with 2 mg high surface ferric phosphate 2 (57FePO4)</description>
    <arm_group_label>HiFePO4 2 fortified rice test meal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women of reproductive age (18 to 49 years) in Thailand&#xD;
&#xD;
          -  BMI &lt; 23 kg/m2&#xD;
&#xD;
          -  Body weight &lt; 65 kg&#xD;
&#xD;
          -  Mildly anaemic to normocythemic (Hb 80-110 g/L)&#xD;
&#xD;
          -  Ferritin &lt; 25 Âµg/L&#xD;
&#xD;
          -  Not pregnant (confirmed by pregnancy test stripe) or lactating&#xD;
&#xD;
          -  No inflammation (CRP &lt; 5 mg/L)&#xD;
&#xD;
          -  Having provided written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Haemoglobinopathies (except heterozygosity for haemoglobin E and alpha-thalassemia 1)&#xD;
&#xD;
          -  Coeliac disease or other chronic diseases of malabsorption that could influence iron&#xD;
             absorption or metabolism&#xD;
&#xD;
          -  Blood donation or significant blood loss due to surgery or accident &lt; 4 months before&#xD;
             start of the study&#xD;
&#xD;
          -  Consumption of vitamin or mineral supplements 2 weeks before start of the study&#xD;
&#xD;
          -  Regular use of medication (except oral contraceptives), that influences iron&#xD;
             absorption&#xD;
&#xD;
          -  Chronic inflammatory disease&#xD;
&#xD;
          -  Smoking&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mahidol University</name>
      <address>
        <city>Salaya</city>
        <state>Nakhon Pathom</state>
        <zip>73170</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 4, 2018</study_first_submitted>
  <study_first_submitted_qc>September 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 6, 2018</study_first_posted>
  <last_update_submitted>September 10, 2021</last_update_submitted>
  <last_update_submitted_qc>September 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Swiss Federal Institute of Technology</investigator_affiliation>
    <investigator_full_name>Prof. Michael B. Zimmermann</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

